Formulation Development
Starton Therapeutics Files PCT & US Patent Application for Continuous Delivery of Lenalidomide & Class of Immunomodulatory Agents
Starton Therapeutics Inc. recently announced it has filed PCT (Patent Cooperation Treaty) and US Non-Provisional patent applications entitled Continuous Delivery of Lenalidomide and Other Immunomodulatory…
TG Therapeutics Announces Publication of Ublituximab Phase 2 Clinical Trial Results
TG Therapeutics, Inc. recently announced the publication of results from the multicenter Phase 2 trial evaluating ublituximab, the Company’s investigational, glycoengineered, anti-CD20 monoclonal antibody, in…
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
Catalent, Inc. recently announced the appointment of Manja Boerman, PhD, to the role of President, Cell & Gene Therapy, effective June 1, 2020. In this…
Aravive & WuXi Biologics Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies
Aravive, Inc. and WuXi Biologics recently announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody platform to develop high-affinity bispecific…
TTP Collaborates With ODx to Develop New Technology to Address Antibiotic Resistance
TTP plc recently announced it has partnered with ODx (ODx Innovations Ltd), a company committed to developing a system for assessing urinary tract infections (UTIs).…
FDA Approves FENSOLVI for Injectable Suspension for Pediatric Patients with Central Precocious Puberty
Tolmar Pharmaceuticals, Inc. recently announced the US FDA has approved its New Drug Application for FENSOLVI (leuprolide acetate) for injectable suspension for the treatment of…
Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership With CytoDyn
Ajinomoto Bio-Pharma Services recently announced it has entered into a manufacturing services agreement with CytoDyn Inc., a late stage biotechnology company, for the supply of the investigational new drug….
Arcturus Therapeutics & Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
Arcturus Therapeutics Holdings Inc. and Catalent, Inc.recently announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to….
Valneva & Pfizer Announce Collaboration to Co-Develop & Commercialize Vaccine
Valneva SE (Valneva) recently announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine candidate….
3M Drug Delivery Systems Launches as Independent Company, Kindeva Drug Delivery
Kindeva Drug Delivery, formerly 3M Drug Delivery Systems, recently announced its launch as an independent company following the acquisition by Altaris Capital Partners in a transaction valued at….
Adare Pharmaceuticals Acquires Orbis Biosciences
Adare Pharmaceuticals, Inc. recently announced it has acquired the pharmaceutical technology company, Orbis Biosciences, Inc. The acquisition of Orbis will….
SPECIAL FEATURE - Prefilled Syringes & Parenteral Manufacturing: Innovations, Challenges & Solutions
Contributor Cindy H. Dubin features several leading companies’ innovations in delivery devices as well as how contract parenteral manufacturers are addressing the ever-demanding challenges, issues, and opportunities related to delivering biologics and small molecules.
DRUG DISCOVERY - Disrupting Drug Discovery From Assay Development to Lead Compound
Zack Gurard-Levin, PhD, says with new innovations in assay methodologies, scientists no longer have to make sacrifices to do quality drug discovery research.
ANALYTICAL SERVICES - Applying Innovative Thinking & Techniques to Reduce Time-to-Market
Ramesh Jagadeesan, PhD, says that while CDMOs have the capacity to support pharmaceutical companies with their analytical requirements for both small and large-scale projects, the opportunity exists to increase speed to market with innovative thinking.
LYOPHILIZATION - Process Monitoring During Freeze-Drying
Gregory A. Sacha, PhD, describes the devices used for process monitoring and how they can be used to detect end points during the process.
FORMULATION FORUM - Application of Nano-Emulsion Technology to Address Unmet Medical Needs: A Case Study of Clopidogrel IV by 505(b)(2) Pathway
Jim Huang, PhD, presents a case study on how the EmulSol technology produces stable, optically clear nano-emulsions without the use of organic solvents and with minimal use of surfactants using a high-pressure or microfluidic homogenization process.
EXECUTIVE INTERVIEW - FSD Pharma Inc.: Is Ultra Micro-PEA the Best Untold Story in Pharma?
Raza Bokhari, MD, CEO of FSD Pharma, discusses how acquiring Prismic will benefit FSD, what makes the ultra-micronized platform unique, and how ultramicro-PEA could be the answer to ending the opioid epidemic.
GLOBAL REPORT - 2019 Global Drug Delivery & Formulation Report: Part 3, Notable Drug Delivery & Formulation Transactions & Technologies of 2019
In part 3 of this 4-part series, PharmaCircle, in collaboration with Drug Development & Delivery, focuses on several notable drug delivery and formulation transactions and technologies.
Almac Group’s Comprehensive Service Offerings to Support Expedited COVID-19 Research Programs & Treatments
Almac Group is an established contract development and manufacturing organization (CDMO) providing an extensive range of integrated services across the drug development lifecycle to the…
Quotient Sciences & CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm
A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was recently announced today by Quotient Sciences, a leading…
